ObjectivesStudies addressing social determinants of health (SDH) in head–neck melanomas (HNM) have only assessed incidence with increasing socioeconomic status. None have investigated a wider scope of SDH or their summed influence on affecting HNM prognosis and follow‐up care.MethodsThis retrospective cohort study analyzed 374,138 HNM in adults from 1975 to 2017 from the NCI‐Surveillance, Epidemiology, and End Results Program (NCI‐SEER) database. Utilizing the NCI‐SEER database, Social Vulnerability Index (SVI) scores were matched to county of residence upon diagnosis. Univariate linear regressions were performed on length of care (months of follow‐up/surveyed) and prognosis (months survival) across various SDH/SVI scores of socioeconomic status, minority and language status, household composition, housing and transportation, and their total composite.ResultsWith increasing overall SVI score, which indicates increasing social vulnerability, months of follow‐up showed significant decreases ranging from 0.04% to 27.63% compared with the lowest vulnerability groups, with the highest differences in nodular melanomas and the lowest with malignant melanomas in giant pigmented nevi. Similarly, months survival significant decreases ranged from 0.19% to 39.84% compared with the lowest SVI scores, with the highest difference in epithelioid cell melanomas and the lowest in amelanotic melanoma. Comprising this overall score trend, decreases with socioeconomic status, minority‐language status, household composition, and housing‐transportation contributed differentially per histology subtype.ConclusionsOur data highlight significant negative trends in HNM prognosis and care with higher total social vulnerability while showing which SDH‐themes quantifiably contribute more to these differences.Level of EvidenceIII Laryngoscope, 2023
Laryngeal angiomyolipoma is a rare tumor with few reported cases in the literature. The case report explains a 62‐year‐old man who presents with dyspnea and found to have a laryngeal angiomyolipoma staining CD34 positive, but HMB45 and Melan‐A negative.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.